Carregant...
Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts
BACKGROUND: Antibody-mediated rejection (AMR) is a major barrier to the long-term function of renal allografts. Platelets and leukocytes, which may be present in red blood cell (RBC) units, express HLA antigens that may increase the risk of AMR by inducing or increasing humoral sensitization to HLA....
Guardat en:
| Publicat a: | Transfusion |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6131050/ https://ncbi.nlm.nih.gov/pubmed/30171817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14800 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|